These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 23563030

  • 41. Estradiol counteracts oxidized LDL-induced asymmetric dimethylarginine production by cultured human endothelial cells.
    Monsalve E, Oviedo PJ, García-Pérez MA, Tarín JJ, Cano A, Hermenegildo C.
    Cardiovasc Res; 2007 Jan 01; 73(1):66-72. PubMed ID: 17097077
    [Abstract] [Full Text] [Related]

  • 42. Taurine protects against low-density lipoprotein-induced endothelial dysfunction by the DDAH/ADMA pathway.
    Tan B, Jiang DJ, Huang H, Jia SJ, Jiang JL, Hu CP, Li YJ.
    Vascul Pharmacol; 2007 May 01; 46(5):338-45. PubMed ID: 17293168
    [Abstract] [Full Text] [Related]

  • 43. Effect of DDAH/ADMA/NOS regulation pathway on cavernae corporum cavernosorum rat penis of different age.
    Wang JH, Chen D, Zhang KQ, Zhang H, Fu Q.
    Andrologia; 2016 Apr 01; 48(3):262-7. PubMed ID: 26011316
    [Abstract] [Full Text] [Related]

  • 44. Pharmacological activation of dimethylarginine dimethylaminohydrolase (DDAH) activity by inorganic nitrate and DDAH inhibition by NG-hydroxy-L-arginine, Nω,Nω-dimethyl-L-citrulline and Nω,Nω-dimethyl-Nδ-hydroxy-L-citrulline: results and overview.
    Bollenbach A, Tsikas D.
    Amino Acids; 2019 Mar 01; 51(3):483-494. PubMed ID: 30536052
    [Abstract] [Full Text] [Related]

  • 45. Regulation of fluid reabsorption in rat or mouse proximal renal tubules by asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase 1.
    Bell T, Araujo M, Luo Z, Tomlinson J, Leiper J, Welch WJ, Wilcox CS.
    Am J Physiol Renal Physiol; 2018 Jul 01; 315(1):F74-F78. PubMed ID: 29513072
    [Abstract] [Full Text] [Related]

  • 46. The L-arginine/NO pathway in end-stage liver disease and during orthotopic liver and kidney transplantation: biological and analytical ramifications.
    Becker T, Mevius I, de Vries DK, Schaapherder AF, zu Vilsendorf AM, Klempnauer J, Frölich JC, Tsikas D.
    Nitric Oxide; 2009 Feb 01; 20(1):61-7. PubMed ID: 18948222
    [Abstract] [Full Text] [Related]

  • 47. Protection of DDAH2 overexpression against homocysteine-induced impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells.
    Liu LH, Guo Z, Feng M, Wu ZZ, He ZM, Xiong Y.
    Cell Physiol Biochem; 2012 Feb 01; 30(6):1413-22. PubMed ID: 23171931
    [Abstract] [Full Text] [Related]

  • 48. DDAH-2 alleviates contrast medium iopromide-induced acute kidney injury through nitric oxide synthase.
    Lin HH, Lee TS, Lin SJ, Yeh YC, Lu TM, Hsu CP.
    Clin Sci (Lond); 2019 Dec 12; 133(23):2361-2378. PubMed ID: 31763675
    [Abstract] [Full Text] [Related]

  • 49. Immunolocalisation and activity of DDAH I and II in the heart and modification post-myocardial infarction.
    Gray GA, Patrizio M, Sherry L, Miller AA, Malaki M, Wallace AF, Leiper JM, Vallance P.
    Acta Histochem; 2010 Sep 12; 112(5):413-23. PubMed ID: 19481782
    [Abstract] [Full Text] [Related]

  • 50. Human recombinant erythropoietin augments serum asymmetric dimethylarginine concentrations but does not compromise nitric oxide generation in mice.
    Desai A, Zhao Y, Warren JS.
    Nephrol Dial Transplant; 2008 May 12; 23(5):1513-20. PubMed ID: 18204093
    [Abstract] [Full Text] [Related]

  • 51. Ammonia reduction with ornithine phenylacetate restores brain eNOS activity via the DDAH-ADMA pathway in bile duct-ligated cirrhotic rats.
    Balasubramaniyan V, Wright G, Sharma V, Davies NA, Sharifi Y, Habtesion A, Mookerjee RP, Jalan R.
    Am J Physiol Gastrointest Liver Physiol; 2012 Jan 01; 302(1):G145-52. PubMed ID: 21903766
    [Abstract] [Full Text] [Related]

  • 52. Lysophosphatidylcholine-induced elevation of asymmetric dimethylarginine level by the NADPH oxidase pathway in endothelial cells.
    Jia SJ, Jiang DJ, Hu CP, Zhang XH, Deng HW, Li YJ.
    Vascul Pharmacol; 2006 Mar 01; 44(3):143-8. PubMed ID: 16309971
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Evidence for dysregulation of dimethylarginine dimethylaminohydrolase I in chronic hypoxia-induced pulmonary hypertension.
    Millatt LJ, Whitley GS, Li D, Leiper JM, Siragy HM, Carey RM, Johns RA.
    Circulation; 2003 Sep 23; 108(12):1493-8. PubMed ID: 12952847
    [Abstract] [Full Text] [Related]

  • 56. Exploring the role of dimethylarginine dimethylaminohydrolase-mediated reduction in tissue asymmetrical dimethylarginine levels in cardio-protective mechanism of ischaemic postconditioning in rats.
    Kaur K, Singh N, Dhawan RK.
    Iran J Basic Med Sci; 2019 Dec 23; 22(12):1415-1423. PubMed ID: 32133059
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Effect of cyclophosphamide and morin-5'-sulfonic acid sodium salt, alone or in combination, on ADMA/DDAH pathway in rats.
    Merwid-Ląd A, Trocha M, Chlebda-Sieragowska E, Sozański T, Magdalan J, Ksiądzyna D, Szuba A, Kopacz M, Kuźniar A, Nowak D, Pieśniewska M, Fereniec-Gołębiewska L, Szeląg A.
    Pharmacol Rep; 2013 Dec 23; 65(1):201-7. PubMed ID: 23563039
    [Abstract] [Full Text] [Related]

  • 60. Involvement of DDAH/ADMA/NOS pathway in nicotine-induced endothelial dysfunction.
    Jiang DJ, Jia SJ, Yan J, Zhou Z, Yuan Q, Li YJ.
    Biochem Biophys Res Commun; 2006 Oct 20; 349(2):683-93. PubMed ID: 16959216
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.